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Abstract  
The aim of this study is to construct the hGAD65 gene and to identify the hGAD65 clone by using PCR & 
RFLP. The samples were derived from normal person & DM patient’s blood. Blood DNA was isolated by salting 
out method and then amplifi ed by PCR with a pair of specifi c primer, GAD65-F-BamH1-807 & GAD65-R-Xho1-
945. The PCR-product was cloned into vector pET-28a and the pET28a-hGAD65-clone was transformed into 
E.coli BL21 competent cells. The pET28a-hGAD65-clone was confi rmed by PCR and RFLP by BamH1 & XhoI. The 
PCR product of pET28a-hGAD65-clone was one band of 159bp and has two bands 5.3 kb and 159 bp by RFLP 
with both restriction enzymes. The GAD65 protein is expressed in 65kD of pET28a-hGAD65-clone. PET28a-
hGAD65-clone was able to recognize by gold standard monoclonal antibody specifi cally. These results indicated 
that the hGAD65 gene inserted into pET28a properly and provided the GAD65 protein expression. 
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Introduction
Type 1 diabetes mellitus (DM) is an 
autoimmune disease characterized by 
destruction of the beta cells of pancreas. This 
type of diabetes decrease insulin production 
that cause an increase of glucose within the 
blood stream (Lukiati et al., 2012). According 
to WHO data, Indonesia is the fourth 
country with the largest number of diabetes 
individuals after China, India, and America. 
The number of people with type 1 diabetes 
in Indonesia is estimated total of 5% - 10 % 
of the overall number of diabetics (Asril and 
Yuniarti, 2012). Type 1 DM commonly occurs 
in childhood, adolescence and manifested in 
adult. Markers of autoimmune of the type 
1 diabetes are Inset Cell Antibodies (ICA), 
Insulin Auto-Antibodies (IAA) and Anti-
Glutamic Acid Decarboxylase (anti-GAD65). 
Patients of type 1 DM are present in 85% of 
Anti-Glutamic Acid Decarboxylase (anti-
GAD65) in the beta cells of pancreas (Truyen 
et al., 2007). 
The previous research reported that anti-
GAD65 autoantibodies were explored from 
beta- pancreatic cells of bovine brain as earlier 
marker detection of type 1 DM (Soeatmadji 
et al., 2005). In this study, material used was 
hGAD65 gene produced from bovine brain as 
original source. However, this original source 
had no equally quality and stability. To 
solve this problem, we constructed hGAD65 
gene into plasmid pET-28a that have same 
characteristic with original source and will 
be able to use as material to produce reagent 
diagnostic kit of type 1 DM.
Materials and Methods
Preparation of DNA from human blood
Human blood samples derived from 
normal people as positive control and 
type 1 DM patients from Saeful Anwar 
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Hospital Malang, coded 5.2jpp and 13.2 jpp 
of positive Type 1 DM clinical-testing. Blood 
DNA was isolated by salting out method 
(Gaaib et al., 2011). Quality & Quantity 
DNA were measured by using Nano Drop 
spectrophotometer and 1% agarose gel 
electrophoresis.
DNA amplifi cation
Blood DNA was amplifi ed by primer 
GAD65-F-BamH1-807 & GAD65-R-XhoI-
945.Our primer was designed specifi cally at 
partial exon 4 of hGAD65 gene. PCR program: 
hot start 94ºC for 1min, denaturation 94ºC for 
30s, annealing 57 ºC for 30 s, and extension 
72ºC for 45s (35 cycles), and then post 
extension 72ºC for 7 min. PCR products 
were measured qualitatively by using 2% 
agarose gel electrophoresis. PCR products 
were sequenced by same primer to identifi ed 
hGAD65 gene.
Preparation of DNA vector
Plasmid pET-28a was transformed 
into E.coli strain BL21 competent cells 
(Novagen) & cultured the clone in LB agar 
medium containing antibiotics kanamycin 
and chloramphenicol antibiotics. DNA 
plasmid was isolated by miniprep method 
( Birnboim and Doly, 1979). The quality 
&quantity of DNA plasmids were measured 
by using Nano Drop spectrophotometer and 
1% agarose gel electrophoresis.
Gene cloning of hGAD65 gene into plasmid 
pET-28a
DNA plasmid and PCR product were 
digested by BamHI and XhoI enzymes. After 
purification by elution method, between 
DNA pET28a-digested and hGAD65-
amplified gene target were ligated by 
T4-DNA ligase. The pET28a-hGAD65-
construction transformed into E. coli BL21 
competent cells and cultured on LB-selected 
agar medium containing kanamycin and 
chloramphenicol antibiotics for blue white 
colony screening.
Confi rmation of the recombinant DNA by 
PCR and RFLP
To confi rm the recombinant DNA, white 
colonies were isolated by miniprep method. 
PCR analysis is using a pairs same GAD65 
primer. RFLP analysis is using restriction 
enzymes BamHI and XhoI. PCR and RFLP 
products were measured qualitatively by 
using 2% agarose gel electrophoresis.
Isolation, characterization and detection of 
recombinant protein from hGAD65 clone by 
specifi c antibody
White colony was cultured in LB 
agar medium containing kanamycin and 
chloramphenicol antibiotics. Protein was 
isolated from supernatant medium by 
Ward & Swiatek method (Ward & Swiatek, 
2009). Protein bands were separated using 
electrophoresis and run by SDS-PAGE 10 
%. Detection of Recombinant protein  by dot 
blot testing using specifi c primer antibody 
from type 1 DM patient serum (Soeatmadji, 
et al., 2005) and Anti-Rabbit IgG labeled 
with Alkaline Phosphatase conjugated 
as secondary antibody. Positive control 
derived from standard protein of GAD65 
ELISA kit and negative control using PBS 
NaN3 1%. Density of GAD65 clone-anti 
hGAD65 reaction measured quantitatively 
by Quantity One program and analyzed by 
Microsoft Excel.  
Results
Target gene of partial exon 4 of hGAD65 
was 159 bp (Figure 1A). The bands of 159 bp 
of partial exon 4 hGAD65 was observed on 
normal person (Lane 3 and 4) and DM patient’s 
blood  (Lane 5 and 6). Figure 1B showed RFLP 
products of pET-28a and target gene hGAD65 
of partial exon 4. The result of alignment 
of sequencing product and gene sequence 
from gene bank showed that positive control 
(R1) have similarity with GAD65 sequence 
from gene bank at partial exon 4 (Figure 1C). 
However, sequence of 13.2jpp, control positive 
(S2) and 5.2jpp had a difference from GAD65 
sequence of gene bank. 
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Figure 2. Selection of hGAD65 gene recombinant identifi ed by specifi c GAD65 primer (A) and selected by BamHI 
and XhoI enzymes (B). Schematic of DNA pET-28a and  hGAD65 gene recombinant.M: Marker; K-: Negative Control; 
R & S: Normal Control; 5.2jpp and 13.2 jpp are Type 1 DM patients.
Figure 1. DNA target and vector preparation. PCR product of hGAD65gene (A). Plasmid pET-28a and PCR product 
was digested by restriction enzyme BamHI and XhoI (B). M: Marker; K-: Negative Control; R1 & S: Normal Control; 
5.2jpp and 13.2 jpp are Type 1 DM patients. Alignment of hGAD65 gene partial exon 4 from gene bank and sequencing 
product(C). NM_001134366.1 : GAD65 from gene bank, R1&S1GAD65: Normal Control, 5.2jpp & 13.2jpp GAD65 : 
type 1 DM patients 
 
 
 
 
 
 
 
    
 
C) NM_001134366.1 GCGTTTCTGCAAGATGTTATGAACATTTTACTTCAGTAT-GTGGTGAA 
R1 GAD65  GCGTTTCTGCAAGATGTTATGAACATTTTACTTCAGTAT-GTGGTGAA 
13.2JPP GAD65 GCGTTTCTGCAAGATGTTATGAACATCTTACTTCAGTATAGTGGTGA- 
S1 GAD65  -----------------------ATTATATTCTTGGA--GAGCTCA- 
5.2JPP GAD65 -----------------------ATTATATTCTTGGA--GAAGAAA- 
 
 
 
 
 
 
 
 
 
  
159 bp 
A) C) 
B)
5,3 kb 
159 bp 
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Identifi cation of recombinant DNA with 
PCR amplifi cation using a pair of GAD65-F-
BamH1-807 & GAD65-R-Xho1-945 primer was 
shown in Figure 2A. We detected one band 
of 159bp to type 1 DM patient and positive 
control from normal person. We also detected 
two bands of RFLP product (Figure 2B,lane 
5-12) as well as the digestion schematic of 
two DNA band, 5.3kb of plasmid &159bp as 
target gene (Figure 2C).
The result of hGAD65 characterization 
by SDS PAGE 10% showed protein band 
with molecule weight of 65kD (Figure 
3A). The protein bands of 65kD was found 
on type 1 DM patient’s blood (Lane 2-8), 
whereas negative control did not show the 
protein band (Lane 9).  Identification of 
recombinant proteins using specifi c antibody 
showed that blue-purple visualization on 
spots of positive control and recombinant 
proteins from type 1 DM patients. Whereas, 
the negative control not showed the blue-
purple visualization (Figure 3B). Binding of 
recombinant proteins and antibody specifi c 
was measured quantitatively by Quantity 
One showed that control positive was higher 
of mean density than type 1 DM patient 
samples (Figure 3C). 
Discussion
DNA band of 159bp was found all of 
samples, both in normal person and type 
1 DM patient’s blood. Why did we use the 
partial exon 4 of GAD65 gene? Previous 
experiments suggested that in partial exon 
4 had two long amphiphilic helical regions 
of epitopes antibody. The epitope can be 
recognized to antibody by presenting of 
GAD65 peptide on T-cell. In diagnostics, 80% 
of type 1 DM had antibody that recognize the 
GAD65 as autoantibody. The compatibility of 
partial exon 4 was proved by expressions of 
amino acid sequence. The region of GAD65 
protein cloned located in N-terminal of exon 
4 (Schwartz et al., 1999).     
The PCR products of target gene 
hGAD65 of partial exon 4 can confi rmed with 
alignment result show that to normal person 
Figure 3. Detection of hGAD65 gene by SDS PAGE 10% (A), and Detection by hGAD65 Antibody Spesifi c (B), 
Statistic Analysis of dot blot (C)  
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( C )  
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(R1) have similarity from gene bank, whereas 
partial exon 4 of type 1 DM patient, both of 
positive control (S1), 5.2jpp and 13.2jpp show 
mutation at nucleotide base that affect to acid 
amino structure. According to Matsukawa 
and Ueno (2007), the mutation of gene 
GAD65 can caused by exposure of peptide 
would require degradation of GAD65. We are 
expected that the mutation of positive control 
show that person have type 1 DM history.  
The PCR products of pET28a-hGAD65-
clone resulted in one band of 159bp indicated 
that a pairs GAD65-F-BamH1-807 and 
GAD65-R-Xho1-945 primers recognized 
target hGAD65 gene specifi cally (Figure 2A 
lane 5-12). This indicates that hGAD65 gene 
at partial exon 4 was inserted into plasmid 
pEt-28a properly.  The good design of 
specifi c primers of target gene would provide 
excellent of DNA recombinant construction 
of specific gene (Tong, 2011). Negative 
control of pET-28a (Lane 1) did not produced 
amplified amplification of hGAD65 gene. 
Lane 12 was positive control which 159bp 
hGAD65 gene derived from blood of normal 
person. According to Matsukawa and 
Ueno (2007), GAD was widely distributed 
among living cells of various organisms 
from mammalians to single cell organisms. 
The previous study suggested that GAD65 
was expressed on leucocytes from healthy 
individuals (Matsukawa and Ueno, 2007). 
RFLP product resulted in two bands 
which suggesting the restriction enzyme 
recognizes sites of vector and target gene. 
According to Hsieh and Williams (2012),when 
the restriction site between the target DNA 
and the plasmid vector ligation have to 
made recombinant in within. To confi rm the 
recombinant restriction site, we could cut the 
DNA recombinant by the same restriction 
enzyme.
Our result found the target protein 
expressed on 65kD (MW) proved that 
hGAD65 gene partial exon 4 was inserted into 
plasmid pET-28a. According to Weber and 
Osborn (2006), SDS- PAGE can determine 
the molecular weight of proteins. Our 
previously study reported the GAD65 is an 
enzyme with molecular weight 65kD which 
as marker autoimmune for type 1 diabetes. 
In diagnostics some diabetes patients, 80% 
of type 1diabetes have antibody that can 
recognize the GAD65 (Soeatmadji et al., 
2005).       
Spots with blue-purple visualization 
on nitrocellulose membrane indicated that 
primer antibody and secondary antibody 
had positive reaction with recombinant 
protein from hGAD65 clone. Positive reaction 
showed that was successfully of labeling of 
pET28a-hGAD65-clone (Soeatmadji et al., 
2005). According to Guillemin et al., (2009), 
dot-blot assay did not use separated protein 
according to their molecular weight, but 
protein could be expressed by the primary 
antibody.  
The dot blot assay also showed color 
intensity to determine titer of antigen-
antibody binding. An antibody titer is used 
to measure of how much antibody that 
recognizes a particular epitope (Kogelnik, et 
al., 2006). Positive control that derived from 
standard protein of GAD65 ELISA kit was 
highest intensity among of all (Figure 3B). 
These result indicated that positive control 
had highest titer of antigen antibody binding. 
The thicker of dot blot color will determine 
that the higher of  GAD concentration 
(Soeatmadji et al., 2005)
Titer antigen-antibody also was 
determined by density mean of product 
of pET28a-hGAD65-clone (Figure 3C). 
Positive control also showed highest mean. 
However, the mean of positive control and 
pET28a-hGAD65-clone product did not show 
significant mean, indicating that product 
of pET28a-hGAD65-clone can be used to 
material kit diagnostic type 1 DM properly. 
In this study, pET-28a- hGAD65 clone 
was inserted properly and GAD65 protein 
of clone was expressed as well. This result 
indicated that partial exon 4 of hGAD65 gene 
showed appropriate with hGAD65 protein 
sequence. 
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